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We examined the effect of dose and transport inhibitors on the pharmacokinetics of phenol red 
as a model drug after application to rat liver surface in-vivo, employing a cylindrical glass cell 
(i.d. 9 mm, area 0.64 cm2), to elucidate the mechanism for drug absorption from liver surface 
membrane.   Absorption ratios of phenol red in 6 h were determined to be 91.1, 91.8 and 
89.9 % at a dose of 0.3, 1 and 3 mg, respectively.   Also, the AUC value for plasma 
concentration profile of phenol red was proportional to the dose.   It is thus suggested that 
absorption process  of phenol red from rat liver surface does not approach saturability.   
Time course of remaining amount of phenol red in glass cell obeyed the first-order kinetics at 
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a dose of 0.3 mg, and its rate constant Ka was calculated to be 0.0069 min-1.   Moreover, no 
significant difference was seen in Ka value within the dose range of 0.3 - 3 mg, which was 
estimated by curve fitting of the plasma concentration profile of phenol red after application 
to rat liver surface in the two-compartment model with first-order absorption.   
2,4-Dinitrophenol (0.3 mg) and probenecid (0.5 and 1 mg), inhibitors of metabolic energy and 
anion transport respectively, had no significant effect on the pharmacokinetics of phenol red 
after application to rat liver surface.   These data demonstrate that specific transport 





Liver site-specific drug delivery is of interest since normal treatment of liver diseases by 
intravenous and oral administration route has been frustrated by inadequate delivery into liver 
as well as toxicity in other organs.   The direct way such as drug application to liver surface 
is supposed to be a useful method for drug delivery to the target site in liver.   In our 
previous paper (Nishida et al 1994), we selected organic anions (phenol red, bromphenol blue 
and bromosulphonphthalein) as model drugs and examined their in-vivo behaviour after 
application to rat liver surface.   Absorption ratios in 6 h of model drugs were relatively 
large (> 59 %) and significant prolongation of blood concentration was observed.   For 
therapeutic application to liver disease, further work is required to elucidate the mechanism 
for drug absorption from liver surface membrane. 
     The main purpose of present study is to obtain the information concerning the 
absorption mechanism from liver surface membrane.   We selected phenol red as a model 
drug, of which absorption ratio was the largest among three organic anions.   First, we 
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analyzed pharmacokinetically the dose dependency in phenol red absorption.   Next, we 
examined the effect of established transport inhibitors of metabolic energy and anion transport 
on the pharmacokinetics of phenol red after application to rat liver surface. 
 
 
Materials and Methods 
 
Chemicals  
Phenol red and 2,4-dinitrophenol were purchased from Nacalai Tesque, Inc., Kyoto, Japan.   
Probenecid was obtained from Wako Pure Chemical Industries, Ltd, Osaka, Japan.   All 
other chemicals were of reagent grade. 
 
In-vivo experiment 
All animal experiments in the present study conformed to the Guideline for Animal 
Experimentation in Nagasaki University. 
     Male Wistar rats (230-250 g) were anaesthetized with sodium pentobarbitone (50 mg 
kg-1, i.p.) and the left femoral artery was cannulated with a polyethylene tube (i.d. 0.5 mm, 
o.d. 0.8 mm, Dural Plastics, Dural, Australia).   A cut of approximately 3 cm was made in 
the middle abdomen, and the common bile duct was cannulated with a polyethylene tube (i.d. 
0.28 mm, o.d. 0.61 mm, Becton Dickinson & Co., Parsippany, NJ, USA).  The body 
temperature of the rats was kept at 37｡C by a heat lamp during the experiment.   Phenol red 
dissolved in pH 7.4 phosphate buffer (0.1 mL) was administered as follows. 
     Application to rat liver surface:   A cylindrical glass cell (i.d. 9 mm, area 0.64 cm2) 
was attached to the rat liver surface at the area of the left lobe with Aron Alpha (Sankyo Co. 
Ltd, Tokyo, Japan).   The phenol red solution (0.3, 1 and 3 mg) was added to the glass cell 
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directly.   In another experiment, transport inhibitor 2,4-dinitrophenol (0.3 mg) or 
probenecid (0.5 or 1 mg) was added into the glass cell simultaneously. 
     Intravenous administration:   The phenol red solution (0.3, 1 and 3 mg) was injected 
into the jugular vein. 
     Blood samples (200 mL) were collected at selected times after dosing from the 
heparinized cannula inserted into femoral artery over 6 h period and centrifuged at 15000 rpm 
for 5 min.   Bile samples were collected at appropriate time intervals for 6 h.   At 6 h after 
the application, urine was collected from the bladder directly by syringe.   Following 
application to rat liver surface, phenol red solution remaining in the glass cell was withdrawn 
at 6 h after dosing.   To study the time course of remaining amount of phenol red in plasma 
and glass cell, and cumulative amount of total phenol red excreted in bile and urine, certain 
experiments were carried out up to 0.5, 1, 2 and 4 h at a dose of 0.3 mg.   The 
concentrations of free phenol red in plasma, bile, urine and remaining solution in glass cell 
were determined spectrophotometrically at 560 nm after dilution with a 1 M NaOH solution.   
The total concentration of free phenol red and its metabolite was measured in the same 
manner after they were subjected to acid hydrolysis (1 M HCl at 100｡C for 30 min) (Hart & 
Schanker 1966).   The concentration of phenol red metabolite was estimated from the 
difference between these values. 
Calculation of moment parameters 
The plasma concentration profiles and biliary excretion rate-time curves of free phenol red 
and its metabolite were analyzed based on statistical moment theory.   Moment parameters 
for plasma concentration profile of free phenol red (AUCp, MRTp) and those for biliary 
excretion rate-time curves of free phenol red (AUCb,f, MRTb,f) and its metabolite (AUCb,m, 
MRTb,m) were calculated using a linear trapezoidal formula and extrapolation to infinite time 




Compartment model analysis 
First, the plasma concentration (Cp) profiles of phenol red at a dose of 0.3, 1 and 3 mg after 
intravenous administration into rat was fitted to the biexponential equation described as 




Hybrid parameters a and b are defined as a + b = K12 + K21 + Kel and .   Vc is the volume 
of the central compartment.   Kel is the first-order elimination rate constant from the central 
compartment.   K12 and K21 are the first-order transfer rate constants between the central 
and peripheral compartment.   These parameters were substituted into the following 
equation for plasma concentration in the application of phenol red to rat liver surface.   Next, 
in the same way, the plasma concentration profile of phenol red after application to rat liver 
surface was fitted in the two-compartment model with first-order absorption, by the nonlinear 
least-squares method (Yamaoka et al 1981).   In this model, the equation for plasma 




Ka is the first-order absorption rate constant for phenol red absorption into the blood stream 






Results and Discussion 
 
Dose dependency 
Figure 1 shows the plasma concentration profiles of phenol red after application to rat liver 
surface at a dose of 0.3, 1 and 3 mg.   At every dose, plasma concentration of phenol red 
reached a maximum at 1 or 1.5 h after dosing, followed by gradual disappearance. 
 
< Fig. 1 > 
 
     Similarly, the shapes of biliary excretion rate-time curves of free phenol red and its 
metabolite after application of phenol red to rat liver surface were almost identical among 
every dose, as shown in Figs 2(a) and (b). 
 
< Fig. 2 > 
 
     Recovery (% of dose) of free phenol red and its metabolite in bile, urine and glass cell 
at a dose of 0.3, 1 and 3 mg are given in Table 1.   Absorption ratios of phenol red in 6 h 
calculated from the remaining amount of phenol red in glass cell were 91.1, 91.8 and 89.9 % 
at a dose of 0.3, 1 and 3 mg, respectively, indicating that the phenol red absorption from rat 
liver surface membrane shows no saturation within the dose range used.   Biliary and 
urinary recovery ratio of phenol red metabolite decreased significantly at a dose of 3 mg, 
suggesting the saturation of metabolic process of phenol red at the highest dose.   Similar 
trend was seen in intravenous administration of phenol red into rats (data not shown). 
     Moment parameters for plasma concentration profile of free phenol red and biliary 
excretion rate-time curves of free phenol red and its metabolite are listed in Table 2.   No 
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significant difference was seen in AUCp/dose value among three doses, suggesting the 
linearity of phenol red absorption from rat liver surface membrane.   As expected from the 
patterns in Figs 1 and 2, MRTp, MRTb,f and MRTb,m values were almost same among three 
doses. 
 
Time course of phenol red distribution in plasma, bile, urine and glass cell 
To assess the absorption characteristics from rat liver surface membrane, we studied the time 
course of phenol red distribution in plasma, bile, urine and glass cell after application to rat 
liver surface at a dose of 0.3 mg (Fig. 3).   Remaining amount of phenol red in plasma 
determined by Cp X Vplasma (plasma volume in rat) was plotted against time in Fig. 3, where 
Vplasma was estimated from the previous paper (Bischoff et al 1971).   A relatively small 
amount of phenol red (< 7.2 %) was detected in plasma.   Cumulative amount of total 
phenol red (free phenol red and its metabolite) excreted in bile and urine reached a plateau 
level at 4 h after dosing and exhibited a similar pattern.   Therefore, there is no significant 
difference in urinary and biliary excretion process of phenol red with respect to rate. 
 
< Fig. 3 > 
 
     On the other hand, remaining amount of phenol red in glass cell declined rapidly.   A 
semi-log plot of the remaining amount of phenol red in glass cell gave a straight line 
(correlation coefficient: 0.99) as shown in Fig. 4, indicating that the phenol red absorption 
from rat liver surface proceeds via first-order.   Its rate constant Ka was calculated to be 
0.0069 min-1.   Also, this result supports the employment of two-compartment model 
incorporating first-order absorption to describe the plasma concentration profile of phenol red 




< Fig. 4 > 
 
Compartment Model Analysis 
Pharmacokinetic parameters for phenol red after intravenous administration into rats are listed 
in Table 3, and used in the following analysis.   The plasma concentration profile of  
phenol red after application to rat liver surface was fitted in the two-compartment model with 
first-order absorption.   Ka and F obtained by curve fitting are given in Table 3.   Figure 1 
shows the simulation curves for plasma concentration of phenol red after application to rat 
liver surface at a dose of 0.3, 1 and 3 mg, which had been reconstructed employing the 
estimated parameters shown in Table 3.   In general, a good agreement was observed 
between fitted lines and experimentally observed data at every dose.   The obtained Ka 
correlated closely with the value determined by elimination profile of phenol red from glass 
cell (Fig. 4), suggesting the validity of this pharmacokinetic model.   No significant 
difference was seen in Ka value at a dose of 0.3, 1 and 3 mg (Table 3).   Accordingly, 
linearity of phenol red absorption from rat liver surface membrane was confirmed.       
 
Effect of transport inhibitors 
From these results, it is suggested that phenol red absorption from rat liver surface membrane 
might be explained mostly by passive diffusion.   The saturative specialized absorption 
process of phenol red in rat lung is known to be inhibited by metabolic inhibitors and 
structurally related organic anions (Enna & Schanker 1973; Gardiner & Schanker 1976).   
Thus, we examined the effect of metabolic inhibitor 2,4-dinitrophenol, which blocks oxidative 
phosphorylation, on the phenol red absorption to determine whether phenol red absorption 
depends on metabolic energy.   Next, we studied the influence of structurally related organic 
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anion probenecid on the phenol red absorption, to know the structural specificity in the 
absorption system of phenol red. 
     Biliary and urinary recovery (% of dose) of free phenol red and its metabolite at a dose 
of 0.3 mg in the presence of 2,4-dinitrophenol (0.3 mg) and probenecid (0.5 and 1 mg) did not 
change compared to control, as shown in Table 4.   Absorption ratios of phenol red in 6 h 
after application to rat liver surface ranged from 89.2 to 94.5 % in the presence of transport 
inhibitors.   2,4-Dinitrophenol and probenecid as transport inhibitors did not cause a 
reduction of the phenol red absorption from rat liver surface. 
     The plasma concentration profiles of phenol red after application to rat liver surface in 
the presence of transport inhibitors was almost same as that of control (data not shown).   
Similar trend was seen in the biliary excretion rate-time curves of free phenol red and its 
metabolite after application to rat liver surface (data not shown). 
     Moment parameters for phenol red after application to rat liver surface in the presence 
of transport inhibitors are given in Table 5, which were of the same magnitude as that of 
control.   Accordingly, it is concluded that transport inhibitor 2,4-dinitrophenol and 
probenecid had no significant effect on the phenol red absorption from rat liver surface 
membrane. 
     Consequently, it is suggested that specialized transport process such as active transport 
might not exist in the phenol red absorption from rat liver surface membrane.   Thus, a 
simple passive diffusion system is considered to play an important role in the phenol red 
absorption from liver surface.   In future, several factors influencing the drug absorption 
from liver surface should be clarified for practical use. 
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